Literature DB >> 10443667

Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentrations in fetuses at risk for 21-hydroxylase deficiency.

S A Wudy1, H G Dörr, C Solleder, M Djalali, J Homoki.   

Abstract

Using routine stable isotope dilution/gas chromatography-mass spectrometry, 17-hydroxyprogesterone, androstenedione, testosterone, dehydroepiandrosterone, androstanediol, and 5alpha-dihydrotestosterone have been profiled in amniotic fluid of midgestation in 77 normal fetuses and 38 untreated or dexamethasone-treated fetuses at risk for 21-hydroxylase deficiency. Dexamethasone was suspended 5-7 days before amniocentesis. In normal fetuses, amniotic fluid concentrations (median, range; nanograms per mL) of 17-hydroxyprogesterone did not reveal a sex difference (1.48, 0.21-4.96), whereas those of androstenedione were lower in females (0.53, 0.00-2.71) than in males (0.93, 0.29-1.98). Testosterone levels were higher in males (0.24, 0.00-0.50) than in females (0.00, 0.00-0.27). No sex difference was found for dehydroepiandrosterone (0.47, 0.19-1.77). Levels of androstanediol and 5alpha-dihydrotestosterone were below the detection limit of our method in most cases. Regarding prenatal diagnosis of 21-hydroxylase deficiency, 17-hydroxyprogesterone and androstenedione presented the diagnostically most valuable steroids and were of equal diagnostic potential. They permitted successful diagnosis in 36 of 37 fetuses at risk: 12 were untreated and unaffected, 13 were treated and unaffected, 4 were untreated and affected (3 salt wasters and 1 simple virilizer), and 8 were treated and affected (5 salt wasters and 3 simple virilizers). In the latter group, one simple virilizer revealed normal steroid concentrations. Isotope dilution/gas chromatography-mass spectrometry, providing the highest specificity in steroid analysis, is proposed for routine use in clinical steroid analysis whenever maximal reliability is requested. Our study provides the first mass spectrometric reference data on amniotic fluid steroid concentrations and underscores the high accuracy of prenatal hormonal diagnosis of 21-hydroxylase deficiency.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443667     DOI: 10.1210/jcem.84.8.5870

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Authors:  C G Brook
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH).

Authors:  Vickie Pasterski; Peter Hindmarsh; Mitchell Geffner; Charles Brook; Caroline Brain; Melissa Hines
Journal:  Horm Behav       Date:  2007-06-06       Impact factor: 3.587

3.  Spatial ability and prenatal androgens: meta-analyses of congenital adrenal hyperplasia and digit ratio (2D:4D) studies.

Authors:  David A Puts; Michael A McDaniel; Cynthia L Jordan; S Marc Breedlove
Journal:  Arch Sex Behav       Date:  2008-02

Review 4.  Prenatal diagnosis and treatment of steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia).

Authors:  R Mathur; M Kabra
Journal:  Indian J Pediatr       Date:  2000-11       Impact factor: 1.967

5.  No relationship between prenatal androgen exposure and autistic traits: convergent evidence from studies of children with congenital adrenal hyperplasia and of amniotic testosterone concentrations in typically developing children.

Authors:  Karson T F Kung; Debra Spencer; Vickie Pasterski; Sharon Neufeld; Vivette Glover; Thomas G O'Connor; Peter C Hindmarsh; Ieuan A Hughes; Carlo L Acerini; Melissa Hines
Journal:  J Child Psychol Psychiatry       Date:  2016-07-27       Impact factor: 8.982

6.  Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior.

Authors:  Pei-Yu Wang; Anna Protheroe; Andrew N Clarkson; Floriane Imhoff; Kyoko Koishi; Ian S McLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

7.  Personality and congenital adrenal hyperplasia: possible effects of prenatal androgen exposure.

Authors:  Greta A Mathews; Briony A Fane; Gerard S Conway; Charles G D Brook; Melissa Hines
Journal:  Horm Behav       Date:  2008-11-28       Impact factor: 3.587

Review 8.  Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism.

Authors:  Andrea C Gore; Katherine M Martien; Khatuna Gagnidze; Donald Pfaff
Journal:  Endocr Rev       Date:  2014-09-11       Impact factor: 19.871

9.  Motor development in individuals with congenital adrenal hyperplasia: strength, targeting, and fine motor skill.

Authors:  Marcia L Collaer; Charles G D Brook; Gerard S Conway; Peter C Hindmarsh; Melissa Hines
Journal:  Psychoneuroendocrinology       Date:  2008-10-19       Impact factor: 4.905

10.  Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids.

Authors:  Doodipala S Reddy
Journal:  Neurochem Int       Date:  2007-06-13       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.